BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17264755)

  • 1. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
    Nakano K; Takahashi S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.
    Nathenson MJ; Sausville E
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):895-919. PubMed ID: 27206640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches.
    Riedel RF
    Cancer; 2012 Mar; 118(6):1474-85. PubMed ID: 21837668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.
    In GK; Hu JS; Tseng WW
    Ther Adv Med Oncol; 2017 Aug; 9(8):533-550. PubMed ID: 28794805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in sarcoma genomics and new therapeutic targets.
    Taylor BS; Barretina J; Maki RG; Antonescu CR; Singer S; Ladanyi M
    Nat Rev Cancer; 2011 Jul; 11(8):541-57. PubMed ID: 21753790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disaggregation-Activated pan-COX Imaging Agents for Human Soft tissue Sarcoma.
    Tae Hong K; Bin Park S; Murale DP; Hoon Lee J; Hwang J; Young Jang W; Lee JS
    Angew Chem Int Ed Engl; 2024 Apr; ():e202405525. PubMed ID: 38607969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.
    Katz D; Azraq Y; Eleyan F; Gill S; Peretz T; Merimsky O
    BMC Cancer; 2016 Aug; 16():616. PubMed ID: 27501793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature.
    Maher OM; Khatua S; Mukherjee D; Olar A; Lazar A; Luthra R; Liu D; Wu J; Ketonen L; Zaky W
    J Neurooncol; 2016 Mar; 127(1):155-63. PubMed ID: 26718692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.
    Ehnman M; Missiaglia E; Folestad E; Selfe J; Strell C; Thway K; Brodin B; Pietras K; Shipley J; Östman A; Eriksson U
    Cancer Res; 2013 Apr; 73(7):2139-49. PubMed ID: 23338608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pericardial sarcoma: a case report and a brief review.
    Pakala A; Gupta R; Lazzara R
    Cardiol Res Pract; 2011 Apr; 2011():853078. PubMed ID: 21559228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis.
    Eckert F; Matuschek C; Mueller AC; Weinmann M; Hartmann JT; Belka C; Budach W
    Radiat Oncol; 2010 Jun; 5():55. PubMed ID: 20553599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.
    Olmos D; Postel-Vinay S; Molife LR; Okuno SH; Schuetze SM; Paccagnella ML; Batzel GN; Yin D; Pritchard-Jones K; Judson I; Worden FP; Gualberto A; Scurr M; de Bono JS; Haluska P
    Lancet Oncol; 2010 Feb; 11(2):129-35. PubMed ID: 20036194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin.
    Guirouilh-Barbat J; Zhang YW; Pommier Y
    Mol Cancer Ther; 2009 Jul; 8(7):1985-94. PubMed ID: 19584235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT
    Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
    Hartmann JT; Patel S
    Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New targets for therapy of sarcoma.
    Magenau JM; Schuetze SM
    Curr Opin Oncol; 2008 Jul; 20(4):400-6. PubMed ID: 18525335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug developments for patients with metastatic soft tissue sarcoma.
    Hartmann JT; Patel S
    Curr Oncol Rep; 2005 Jul; 7(4):300-6. PubMed ID: 15946590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel treatment strategies for soft tissue sarcoma.
    Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.